Evidence map›Paper›PMID 39930309›Full record

ArticlePharmaceutical research2025

Prediction of the Extent of Blood-Brain Barrier Transport Using Machine Learning and Integration into the LeiCNS-PK3.0 Model.

Berfin Gülave, Helle W van den Maagdenberg, Luke van Boven, Gerard J P van Westen, Elizabeth C M de Lange, J G Coen van Hasselt

Abstract read
In one paragraph

Article in Pharmaceutical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Antibody-drug conjugate engineering: from design to efficacy and safety.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Berfin GülaveSystems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-8954-882X
Helle W van den Maagdenberg *Systems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Luke van Boven *Systems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Gerard J P van WestenMedicinal Chemistry, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
Elizabeth C M de LangeSystems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands.
J G Coen van HasseltSystems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands. coen.vanhasselt@lacdr.leidenuniv.nl.

Funding

European Union's Horizon2020 848068
6 · The paper itself

Abstract

introductionThe unbound brain-to-plasma partition coefficient (K

methodsRat K

resultsAmong all ML algorithms, a random forest showed the best predictive performance for K

conclusionsThe developed random forest QSPR model for K

Indexed as

Blood-Brain BarrierCentral Nervous System AgentsMachine LearningModels, BiologicalAlgorithmsAnimalsBiological TransportBrainPharmaceutical PreparationsQuantitative Structure-Activity RelationshipRatsCentral Nervous System AgentsPharmaceutical PreparationsKp,uu,BBBLeiCNS-PK3.0machine learningrandom forest

Identifiers

PMID39930309
PMCPMC11880073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.